MedTech, short for medical technology, is the broad category of devices, equipment, software, and diagnostics used to diagnose, treat, monitor, or prevent disease. It covers everything from a simple bandage or walking cane to a robotic surgical system or an AI-powered colonoscopy tool. The global medtech industry reached $584 billion in revenue in 2025, making it one of the largest sectors in healthcare.
If you’ve worn a heart monitor, used a blood glucose sensor, had an MRI, or even put on a pair of prescription glasses, you’ve used medtech. The term gets tossed around in news headlines and job listings, but it has a specific meaning rooted in how regulators define medical devices and the companies that make them.
What Counts as a Medical Device
Under U.S. law, a medical device is any instrument, machine, implant, or similar product intended for use in diagnosing or treating disease, or for affecting the structure or function of the body. The key distinction from drugs: a medical device doesn’t work primarily through chemical action or metabolism. An insulin pump is a device; the insulin inside it is a drug. An artificial hip joint is a device; a painkiller you take after surgery is not.
The FDA recognizes roughly 1,700 different types of medical devices, grouped into 16 specialty panels. That range is enormous. It includes:
- Implantable devices like pacemakers, neurostimulators for chronic pain or Parkinson’s disease, and artificial joints
- Wearable sensors like continuous glucose monitors that track blood sugar in real time and communicate with insulin pumps
- Diagnostic equipment like MRI machines, X-rays, ultrasound systems, and blood testing kits
- Assistive devices like wheelchairs, prosthetic limbs, hearing aids, and braces
- Surgical instruments from basic scalpels to robotic-assisted surgical systems
Radiation-emitting products with a medical use, such as X-ray machines and medical lasers, also fall under the medtech umbrella.
Software as a Medical Device
Medtech isn’t just physical hardware anymore. Software that runs on a general-purpose computer (your phone, a tablet, a laptop) and serves a medical purpose is classified as “Software as a Medical Device,” or SaMD. An app that uses an AI algorithm to analyze medical images and flag potential tumors qualifies. So does software that takes data from a heart monitor and generates a clinical diagnosis.
Not every health-related app counts, though. Software that handles scheduling, encrypts data for transmission, or monitors equipment performance is excluded. The line is medical purpose: if the software itself is making or informing a clinical decision, it’s regulated as a medical device. If it’s just moving data around or handling administrative tasks, it’s not.
How MedTech Differs From BioTech and HealthTech
These three terms overlap in casual conversation, but they describe different things. Biotech focuses on biological and chemical innovations, think gene editing tools like CRISPR or cancer immunotherapies like CAR-T. Biotech products typically work through chemical or biological action in the body, which is exactly what separates them from medical devices.
HealthTech (or health IT) generally refers to the digital infrastructure of healthcare: electronic health records, telemedicine platforms, hospital management systems. MedTech sits in between, covering the physical devices, diagnostics, imaging systems, and increasingly the clinical software that directly touches patient care. A robotic surgery system is medtech. The hospital’s billing software is health IT. A new cancer drug is biotech.
How Devices Get Approved
The FDA assigns every medical device to one of three risk-based classes, and each class faces different regulatory hurdles before it can reach patients.
- Class I (lowest risk): Simple devices like tongue depressors, elastic bandages, and manual stethoscopes. These are subject to general safety controls but are often exempt from premarket review.
- Class II (moderate risk): Devices like powered wheelchairs, pregnancy test kits, and some surgical instruments. These require general controls plus special controls, and most need to demonstrate they’re substantially similar to a device already on the market (a process called 510(k) clearance).
- Class III (highest risk): Life-sustaining or life-supporting devices like implantable pacemakers, heart valves, and certain neural stimulators. These typically require premarket approval, the most rigorous pathway, involving clinical trial data proving safety and effectiveness.
After approval, the FDA continues monitoring devices through post-market surveillance, tracking adverse events and performance issues once real patients start using them.
Real-World Impact on Patient Outcomes
Medical technology has quietly reshaped what’s possible in healthcare, even if it doesn’t dominate headlines the way breakthrough drugs do. In a physician survey covering health outcomes from 1990 to 2015, doctors attributed about 20% of gains in patient survival and reduced illness to improvements in diagnostics, 14% to surgical procedures and techniques, and 11% to medical devices specifically. Pharmaceuticals accounted for the largest share at 56%, but the combined contribution of medtech categories was substantial.
Some of the most visible changes are in how and where patients receive care. Remote monitoring devices, continuous glucose sensors, and wearable heart monitors now allow many patients to be managed at home rather than in a hospital. That shift has practical consequences: fewer overnight stays, lower costs, and less disruption to daily life.
Where Medtech Is Headed
Several technologies are rapidly changing what medtech can do. AI-assisted diagnostics are already in clinical use. One AI colonoscopy system, trained on millions of procedure videos, scans every visual frame during a colonoscopy and has been shown to reduce missed polyps by up to 50%. AI tools are also being applied to detect heart disease in real time.
Robotic-assisted surgery continues to expand. Surgeons using robotic systems can perform minimally invasive procedures with greater precision, which translates to fewer complications, shorter hospital stays, and faster recovery for patients. Meanwhile, a newer concept called “digital twins” creates a virtual model of an individual patient by combining clinical, physiological, and lifestyle data. Clinicians can use these models to predict outcomes and personalize treatment plans before making decisions on the actual patient.
On the interventional side, the FDA has approved renal denervation, a device-based procedure that can lower blood pressure in some patients without additional medication, targeting hypertension through tiny electrodes rather than drugs.
The Medtech Industry by the Numbers
The medtech industry recorded its seventh consecutive year of revenue growth in 2025, with top companies forecasting 6% to 7% annual growth. The five largest medtech companies by revenue give a sense of the scale involved:
- Medtronic: $32.4 billion
- Johnson & Johnson MedTech: $30.4 billion
- Siemens Healthineers: $23.4 billion
- Medline Industries: $23.2 billion
- Stryker: $20.5 billion
These companies span the full range of medtech, from implantable cardiac devices and surgical robotics to imaging systems and basic medical supplies. The industry employs hundreds of thousands of engineers, regulatory specialists, clinical researchers, and manufacturing professionals worldwide, making “medtech” not just a product category but a major career field in its own right.